Most macromolecule drugs need to be injected to provide biologic effect. Pharmaceutical companies have tried to transform injectables into convenient oral capsules and tablets that overcome the absorption barrier in the intestinal tract over decades, but with limited success. Injections are associated with risk of local reaction, needle fear and pain. Biograil’s novel technology is a capsule that contains a simple and cost-efficient device for delivery of drugs into the gut wall, providing an efficient, environmental friendly and convenient option for oral drugs which otherwise needs to be injected.
Location: Denmark, Capital Region of Denmark, Copenhagen
Investors 1
| Date | Name | Website |
| - | Verve Vent... | verve.vc |
Mentions in press and media 2
| Date | Title | Description | Source |
| 09.09.2023 | Bio-Innovation Blooms: 15 Cutting-Edge Biotechnology Startup... | Denmark, known for its picturesque landscapes and rich culture, is also a fertile ground for biotech... | eustartup.... |
| 18.02.2022 | Biograil Secures Seed 2 Funding for Oral Delivery Device for... | February 17, 2022 COPENHAGEN, DENMARK, Jan 17th, 2022 – Biograil ApS, a Copenhagen based biotech co... | htgf.de/en... |